Merryn Voysey
Overview
Explore the profile of Merryn Voysey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
12122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davies H, Kyohere M, Tusubira V, Amone A, Wamawobe A, Komugisha C, et al.
Open Forum Infect Dis
. 2025 Mar;
11(Suppl 3):S157-S164.
PMID: 40070704
Background: Epidemiological evidence about the etiology and antimicrobial resistance of neonatal infections remains limited in low-resource settings. We aimed to describe the etiology of neonatal infections in a prospective observational...
2.
Feng S, Bibi S, Aley P, Cappuccini F, Clutterbuck E, Conlin K, et al.
J Infect
. 2025 Jan;
90(2):106423.
PMID: 39826861
Objectives: Evaluation of the safety and humoral immunogenicity of ChAdOx1 nCoV-19 as a fourth dose booster in individuals who have had two initial doses of the vaccine and a third...
3.
Conlin K, Jenkin D, de Whalley P, Weckx L, Folegatti P, Bibi S, et al.
Vaccine
. 2024 Dec;
45():126582.
PMID: 39675209
Objectives: To identify demographic, clinical and immunological factors associated with adverse COVID-19 outcomes. Methods: A large randomised controlled trial of ChAdOx1 nCoV-19 was undertaken in Brazil. Participants were randomised 1:1...
4.
Bajaj S, Chen S, Creswell R, Naidoo R, Tsui J, Kolade O, et al.
Lancet Digit Health
. 2024 Oct;
6(11):e778-e790.
PMID: 39455191
Background: Understanding underlying mechanisms of heterogeneity in test-seeking and reporting behaviour during an infectious disease outbreak can help to protect vulnerable populations and guide equity-driven interventions. The COVID-19 pandemic probably...
5.
Qadri F, Khanam F, Zhang Y, Biswas P, Voysey M, Mujadidi Y, et al.
Lancet
. 2024 Oct;
404(10461):1419-1429.
PMID: 39396349
Background: WHO currently recommends a single dose of typhoid conjugate vaccine (TCV) in high-burden countries based on 2-year vaccine efficacy data from large randomised controlled trials. Given the decay of...
6.
Williams L, Emary K, Phillips D, Hay J, Larwood J, Ramasamy M, et al.
Vaccine
. 2024 Jul;
42(21):126167.
PMID: 39060202
Background: For pathogens which cause infections that present asymptomatically, evaluating vaccine efficacy (VE) against asymptomatic infection is important for understanding a vaccine's potential epidemiological impact. Regular testing for subclinical infections...
7.
Feng S, McLellan J, Pidduck N, Roberts N, Higgins J, Choi Y, et al.
Health Technol Assess
. 2024 Jul;
28(34):1-109.
PMID: 39046101
Background: Vaccination of infants with pneumococcal conjugate vaccines is recommended by the World Health Organization. Evidence is mixed regarding the differences in immunogenicity and efficacy of the different pneumococcal vaccines....
8.
El Safadi D, El Safadi D, Hitchins L, Hitchins L, Howard A, Howard A, et al.
J Infect Dis
. 2024 Jul;
231(1):e17-e27.
PMID: 39013016
Background: Pneumococcal carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is not well understood. Methods: Nasal wash samples from adults without close contact with young children...
9.
Murray J, Martins R, Greenland M, Cruz S, Altafim E, Arteche A, et al.
Prev Sci
. 2024 Jul;
25(5):834-848.
PMID: 38954125
Violence is a major public health problem globally, with the highest rates in low- and middle-income countries (LMICs) in the Americas and southern Africa. Parenting programmes in high-income countries can...
10.
Naidoo R, Lambert B, Voysey M, Shretta R, Keene C, Wanat M, et al.
BMJ Open
. 2024 Jun;
14(6):e077271.
PMID: 38885988
Introduction: In 2020, the UK government established a large-scale testing programme to rapidly identify individuals in England who were infected with SARS-CoV-2 and had COVID-19. This comprised part of the...